Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
Current price $0.0005
Latest analyst grade actions
1067 daily bars · split adjusted
Daily · Wilder smoothing
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 96.95 | Oscillator | Sell |
| Stochastic %K (14, 3, 3) | 50.00 | Oscillator | Neutral |
| Williams %R (14) | -50.00 | Oscillator | Neutral |
| MACD (12, 26, 9) | 0.00 (Hist -0.00) | Oscillator | Sell |
| Average Directional Index (14) | NaN (+DI 96.9 / -DI 3.1) | Trend | Buy |
| EMA 20 | 0.00 | MA | Buy |
| SMA 20 | 0.00 | MA | Buy |
| EMA 50 | 0.00 | MA | Buy |
| SMA 50 | 0.00 | MA | Buy |
| SMA 200 | 0.00 | MA | Strong Buy |
Stock news · updated daily
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Jul 31, 2021 | — | -0.00 | — | $180 |
| Jun 21, 2021 | — | -0.00 | — | $95 |
| Mar 22, 2021 | — | -0.00 | — | $47.23K |
| Jan 29, 2021 | — | -0.00 | — | $62.34K |
| Sep 21, 2020 | — | -0.00 | — | $961 |
| Jun 22, 2020 | — | -0.00 | — | -$211 |
TTM vs. 5-year historical average (annual ratios)
| Metric | ABMT | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | -0.1x | -10.1x · sector 20.7x | Discount |
| Forward P/E | — | — | n/a |
| Price / Book | -0.0x | -1.1x | Discount |
| Price / Sales | 0.2x | 97.0x | Discount |
| EV / EBITDA | -41.3x | -38.5x | In line |
| Return on equity | 6.3% | — | Weak |
| Gross margin | 81.9% | 45.9% | Above hist. |
| Debt / Equity | -0.86 | -0.77 | Conservative |
| Piotroski / Altman Z | 3/9 | Z -68.00 | Distress |
Discounted cash flow model
SEC EDGAR filings · last 12 months
Proxy statement (DEF 14A) disclosures
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Oct 26, 21 | Advanced Biomedical Technologies Inc. | director | A-Award | 100,000 @ $0.0731 | $7.31K |
| Oct 26, 21 |
| Advanced Biomedical Technologies Inc. |
| director |
| A-Award |
| 200,000 @ $0.0731 |
| $14.62K |
| Sep 23, 21 | Advanced Biomedical Technologies Inc. | officer: Chief Medical Officer | A-Award | 80,000 @ $0.117 | $9.36K |
| Oct 30, 19 | Advanced Biomedical Technologies Inc. | director, officer: President | A-Award | 100,000 @ $0.153 | $15.30K |
| Oct 30, 20 | Advanced Biomedical Technologies Inc. | director, officer: CFO | A-Award | 150,000 @ $0.153 | $22.95K |
| Mar 9, 20 | Advanced Biomedical Technologies Inc. | other: Chief Medical Officer | D | 0 | — |
| Oct 30, 19 | Advanced Biomedical Technologies Inc. | director, officer: President | A-Award | 100,000 @ $0.061 | $6.10K |
| Oct 30, 19 | Advanced Biomedical Technologies Inc. | director, officer: CFO | A-Award | 150,000 @ $0.061 | $9.15K |
